MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TNGX has $435,792K in assets. $44,286K in debts. $157,828K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2737.80%
Quick Ratio
2737.80%
Cash Ratio
1101.38%
Debt to Asset Ratio
10.16%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating leaseright-of-useasset...
    • Others
Liabilities Breakdown
    • Additionalpaid-incapital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
157,828 112,279 58,338 39,272
Marketable securities
222,011 230,859 94,473 141,513
Restricted cash
0 428 428 428
Prepaid expenses and other current assets
12,488 10,190 10,540 8,887
Total current assets
392,327 353,756 163,779 190,100
Property, plant and equipment, gross
17,322 17,406 17,406 17,396
Less accumulated depreciation
10,941 10,538 10,060 9,610
Property and equipment, net
6,381 6,868 7,346 7,786
Operating leaseright-of-useassets
34,652 35,624 36,582 37,555
Restricted cash, net of current portion
2,139 2,139 2,139 2,139
Other assets
293 303 290 310
Total assets
435,792 398,690 210,136 237,890
Accounts payable
2,430 1,182 2,229 2,607
Accrued expenses and other current liabilities
9,068 17,759 13,113 11,510
Operating lease liabilities
2,832 2,738 3,102 2,534
Deferred revenue
-0 0 23,374
Total current liabilities
14,330 21,679 18,444 40,025
Operating lease liabilities, net of current portion
29,956 30,832 31,661 32,474
Deferred revenue, net of current portion
-0 0 30,437
Total liabilities
44,286 52,511 50,105 102,936
Common stock, 0.001 par value 400,000,000 and 200,000,000 shares authorized at march 31, 2026 and december 31, 2025, respectively 144,162,543 and 135,940,454 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
144 136 112 111
Additionalpaid-incapital
1,040,143 948,971 724,201 715,036
Accumulated other comprehensive (loss) income
-115 224 121 94
Accumulated deficit
-648,666 -603,152 -564,403 -580,287
Total stockholders' equity
391,506 346,179 160,031 134,954
Total liabilities and stockholders' equity
435,792 398,690 210,136 237,890
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$222,011K (40.25%↑ Y/Y)Cash and cashequivalents$157,828K (170.11%↑ Y/Y)Prepaid expenses andother current assets$12,488K (60.56%↑ Y/Y)Property, plant andequipment, gross$17,322K (4.83%↑ Y/Y)Total current assets$392,327K (74.42%↑ Y/Y)Operatingleaseright-of-useassets$34,652K (-12.71%↓ Y/Y)Property and equipment,net$6,381K (-15.36%↓ Y/Y)Restricted cash, net ofcurrent portion$2,139K (0.00%↑ Y/Y)Other assets$293K (29200.00%↑ Y/Y)Less accumulateddepreciation$10,941K (21.77%↑ Y/Y)Total assets$435,792K (58.87%↑ Y/Y)Total liabilities andstockholders' equity$435,792K (58.87%↑ Y/Y)Total stockholders'equity$391,506K (134.78%↑ Y/Y)Total liabilities$44,286K (-58.82%↓ Y/Y)Accumulated deficit-$648,666K (-19.81%↓ Y/Y)Accumulated othercomprehensive (loss) income-$115K (-159.28%↓ Y/Y)Additionalpaid-incapital$1,040,143K (46.94%↑ Y/Y)Operating leaseliabilities, net of current...$29,956K (-12.21%↓ Y/Y)Total currentliabilities$14,330K (-60.10%↓ Y/Y)Common stock, 0.001 parvalue 400,000,000 and...$144K (33.33%↑ Y/Y)Accrued expenses andother current...$9,068K (-12.59%↓ Y/Y)Operating leaseliabilities$2,832K (0.28%↑ Y/Y)Accounts payable$2,430K (-24.98%↓ Y/Y)

TNGX_BIG

Tango Therapeutics, Inc. (TNGX)

TNGX_BIG

Tango Therapeutics, Inc. (TNGX)